IDEXX Laboratories Inc
NASDAQ:IDXX
IDEXX Laboratories Inc
Net Income (Common)
IDEXX Laboratories Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Net Income (Common)
$866.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
17%
|
CAGR 10-Years
16%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.8B
|
CAGR 3-Years
106%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is IDEXX Laboratories Inc's Net Income (Common)?
Net Income (Common)
866.5m
USD
Based on the financial report for Mar 31, 2024, IDEXX Laboratories Inc's Net Income (Common) amounts to 866.5m USD.
What is IDEXX Laboratories Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
16%
Over the last year, the Net Income (Common) growth was 24%. The average annual Net Income (Common) growth rates for IDEXX Laboratories Inc have been 9% over the past three years , 17% over the past five years , and 16% over the past ten years .